Location History:
- München, DE (2004 - 2006)
- Münich, DE (2002 - 2012)
- Munich, DE (2005 - 2023)
Company Filing History:
4 out of 40 
1 out of 1 
1 out of 3 Years Active: 2002-2025
Title: Gerd Sutter: Pioneering Innovations in Vaccinia Virus Research
Introduction
Gerd Sutter, a prominent inventor based in Munich, Germany, has made significant contributions to medical research through his pioneering innovations. With a remarkable portfolio of 11 patents, Sutter has focused on the development of advanced viral strains for therapeutic applications.
Latest Patents
Among his notable inventions is the "Immuno-modulated replication-efficient Vaccinia virus strain." This groundbreaking invention involves new strains of the Vaccinia virus (designated as IOVA) and its derivatives, which are positioned for use in medicine. Such innovative approaches hold the potential for transformative applications in immunotherapy.
Career Highlights
Sutter has been associated with esteemed institutions such as the GSF-Forschungszentrum für Umwelt und Gesundheit GmbH. His work in these research centers has provided him with the platform to advance his research and inventions, contributing to both scientific understanding and applied medical therapies.
Collaborations
Throughout his career, Gerd Sutter has collaborated with notable professionals, including Volker Erfle and Marion Ohlmann. These partnerships have enriched his research endeavors, fostering an environment of innovation and exploration in the field of viral therapeutics.
Conclusion
Gerd Sutter's inventive spirit and dedication to medical research have positioned him as an influential figure in the field of virology. His patents not only highlight his innovative capabilities but also pave the way for future advancements in medical treatments through immuno-modulated approaches. Sutter's work continues to inspire those in the realm of inventiveness and scientific exploration.